MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, EMMA made $1,982K in revenue. -$4,253K in net income. Net profit margin of -214.58%.

Income Overview

Revenue
$1,982K
Net Income
-$4,253K
Net Profit Margin
-214.58%
EPS
-$0.05
Unit: Thousand (K) dollars
Revenue Breakdown
    • Endari US
    • Endari International
    • Product And Service Other

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues, net
1,982 3,852 3,378 2,817
Cost of goods sold
168 235 247 150
Gross profit
1,814 3,617 3,131 2,667
Research and development
40 31 50 56
Selling
747 898 655 674
General and administrative
1,850 1,802 1,731 2,307
Total operating expenses
2,637 2,731 2,436 3,037
Loss from operations
-823 886 695 -370
Loss on debt extinguishment
-76 -691 -296 -212
Change in fair value of warrant derivative liabilities
-2 -2 2 4
Change in fair value of conversion feature derivative, notes payable
-235 -324* --
Realized gain on investment in convertible bond
-1,062* --531
Loss (gain) on lease modification
--738* -861
Foreign exchange gain (loss)
-130 76 -32 134
Interest and other income (net)
61 65 65 67
Interest expense
2,126 2,269 1,931 1,678
Total other expense
-2,508 -2,821 -2,192 -1,355
Loss before income taxes
-3,331 -1,935 -1,497 -1,725
Income tax provision
4 16 579 -590
Net loss
-3,335 -1,951 -2,076 -1,135
Unrealized gain (loss) on debt securities available for sale (net of tax)
-940 -2,259 -1,734 3,715
Reclassification adjustment for gain included in net gain
-0 0 354
Foreign currency translation adjustment
22 11 14 -33
Other comprehensive income (gain)
-918 -2,248 -1,720 4,036
Comprehensive loss
-4,253 -4,199 -3,796 2,901
Basic EPS
-0.05 -0.065 -0.03 -0.02
Diluted EPS
-0.05 -0.065 -0.03 -0.02
Basic Average Shares
70,188,263 64,558,467 63,865,571 63,865,571
Diluted Average Shares
70,188,263 64,558,467 63,865,571 63,865,571
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$4,253K (-99.48%↓ Y/Y)Net loss-$3,335K (-43.13%↓ Y/Y)Other comprehensiveincome (gain)-$918K (-563.64%↓ Y/Y)Foreign currencytranslation adjustment$22K (450.00%↑ Y/Y)Endari US$1,376K Endari International$583K Product And ServiceOther$23K (-84.97%↓ Y/Y)Loss before incometaxes-$3,331K (-43.21%↓ Y/Y)Income tax provision$4K (0.00%↑ Y/Y)Unrealized gain (loss) ondebt securities...-$940K (-584.54%↓ Y/Y)Revenues, net$1,982K (-17.62%↓ Y/Y)Total other expense-$2,508K (-86.33%↓ Y/Y)Loss from operations-$823K (16.02%↑ Y/Y)Interest and other income(net)$61K (-16.44%↓ Y/Y)Gross profit$1,814K (-16.83%↓ Y/Y)Cost of goods sold$168K (-25.33%↓ Y/Y)Interest expense$2,126K (69.27%↑ Y/Y)Change in fair value ofconversion feature...-$235K (-245.06%↓ Y/Y)Foreign exchange gain(loss)-$130K (14.47%↑ Y/Y)Loss on debtextinguishment-$76K (53.66%↑ Y/Y)Total operatingexpenses$2,637K (-16.58%↓ Y/Y)Change in fair value ofwarrant derivative...-$2K (77.78%↑ Y/Y)General andadministrative$1,850K (-20.91%↓ Y/Y)Selling$747K (15.63%↑ Y/Y)Research and development$40K (-77.27%↓ Y/Y)

Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences, Inc. (EMMA)